Provided by Tiger Fintech (Singapore) Pte. Ltd.

HCW Biologics Inc.

4.57
-0.2900-5.97%
Post-market: 4.570.00000.00%19:39 EDT
Volume:45.38K
Turnover:217.78K
Market Cap:9.50M
PE:-0.15
High:5.15
Open:4.81
Low:4.50
Close:4.86
Loading ...

HCW Biologics Sees Strong Investor Interest in June

TIPRANKS
·
14 Jun

HCW Biologics Meets Nasdaq Listing Requirements in May 2025

TIPRANKS
·
05 Jun

HCW Biologics Inc. Announces $5 Million At-The-Market Follow-On Offering Under NASDAQ Rules

Reuters
·
05 Jun

HCW Biologics Secures $7 Million License Agreement with WY Biotech for Novel Immunotherapy Development

Reuters
·
04 Jun

HCW Biologics Completes Deliverable and Solidifies License Agreement With Wy Biotech

THOMSON REUTERS
·
04 Jun

HCW Biologics Inc. Issues Additional Shares to Armistice Capital, Retains Warrants for 139,000 Shares

Reuters
·
31 May

BUZZ-David Di Pilla's HCW fund surges on partially deferring Healthscope rental payments

Reuters
·
30 May

HCW Biologics Is Maintained at Buy by Maxim Group

Dow Jones
·
29 May

Maxim Group Keeps Their Buy Rating on HCW Biologics (HCWB)

TIPRANKS
·
29 May

HCW Biologics price target lowered to split-adjusted $35 from $120 at Maxim

TIPRANKS
·
29 May

HCW Biologics Issues Shares Through Warrant Exercise

TIPRANKS
·
24 May

HCW Biologics Inc. Announces Armistice Capital Exercises Pre-Funded Warrants for 126,000 Shares, Retains Rights to 210,000 More

Reuters
·
24 May

HCW Biologics Enters Securities Purchase Agreement

TIPRANKS
·
21 May

Director Garrett Scott T Acquires Common Shares of HCW Biologics Inc

Reuters
·
21 May

HCW Biologics Inc. Announces Conversion of Convertible Bridge Notes into Common Stock

Reuters
·
21 May

HCW Biologics Q1 EPS $(0.05) Up From $(0.20) YoY, Sales $5.07K Down From $1.13M YoY

Benzinga
·
16 May

Press Release: HCW Biologics Reports First Quarter 2025 Business Highlights and Financial Results

Dow Jones
·
16 May

HCW Biologics Inc. Announces $5 Million Follow-On Offering with Warrants to Boost Immunotherapy Development

Reuters
·
16 May

HCW Biologics Announces Pricing of $5.0 Million Follow-on Offering Priced at-the-Market Under Nasdaq Rules

THOMSON REUTERS
·
14 May

Nasdaq Rises Over 1%; Under Armour Posts Strong Q4 Sales

Benzinga
·
13 May